Calculation of Filing Fee Table
Form S-8
(Form Type)
Pacific Biosciences of California, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Security Type | | Security Class Title | | Fee Calculation Rule | | Amount Registered(1) | | Proposed Maximum Offering Price Per Share | | Proposed
Maximum Aggregate Offering Price | | Fee Rate | | Amount of Registration Fee |
| Equity | | Common Stock, $0.001 par value per share | | Other | | 20,000,000(2) | | $ 1.67(3) | | $ | 33,400,000 | | | $ | 0.0001476 | | | $ | 4,929.84 | |
| Total Offering Amounts | | | | | | | | | | $ | 33,400,000 | | | | | $ | 4,929.84 | |
| Total Fee Offsets | | $ | — | |
| Net Fee Due | | $ | 4,929.84 | |
(1)Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock that become issuable under the 2020 Equity Incentive Plan (the “2020 Plan”) by reason of an event such as any stock split, stock dividend, recapitalization or similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding shares of Common Stock.
(2)Represents 20,000,000 shares of Common Stock reserved for issuance pursuant to awards under the 2020 Plan.
(3)Estimated in accordance with Rules (c) and (h) of Rule 457 of the Securities Act solely for the purposes of calculating the registration fee on the basis of $1.67 per share, which represents the average of the high and low price per share of the Registrant’s Common Stock on June 18, 2024, as reported on The Nasdaq Global Select Market.
